Literature DB >> 10692986

Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion.

K Yu1, C Mitchell, Y Xing, R S Magliozzo, B R Bloom, J Chan.   

Abstract

OBJECTIVE: To test the toxicity of reactive nitrogen intermediates (RNI), including authentic nitric oxide (NO), nitrogen dioxide (NO2), and peroxynitrite anion (ONOO-), a potent oxidant derived from NO and superoxide anion, on various mycobacterial strains including M. tuberculosis.
DESIGN: Relatively avirulent mycobacteria including M. smegmatis and BCG, as well as the pathogenic M. Bovis Ravenel and M. tuberculosis Erdman and the clinical isolate M160 (also known as the C strain) were tested for their susceptibility to the toxic effects of NO, NO2, and ONOO-, Deaerated, NO-saturated solutions as well as an anaerobic in vitro system in which mycobacteria can be exposed to desired concentrations of authentic NO or NO2, were employed in these studies. An in vitro ONOO- killing assay was used to examine the adverse effects of this NO-derived oxidant on the various strains of mycobacteria.
RESULTS: Both NO and NO2 exhibit antimycobacterial activity, with the former being more potent. Results obtained using ONOO- killing assay revealed that while avirulent mycobacteria including BCG and M. smegmatis are susceptible to this NO-derived oxidant, the virulent Erdman strain of M. tuberculosis and M. bovis, as well as the clinical tuberculous isolate M160, are remarkably resistant.
CONCLUSION: These results suggest that the interactions between RNI and various species of mycobacteria could be highly specific. And since activated macrophages produce peroxynitrite, the significance of the ONOO- resistance of M. tuberculosis strains in relation to intracellular survival deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10692986     DOI: 10.1054/tuld.1998.0203

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  45 in total

1.  Cloning, expression, purification, crystallization and preliminary X-ray studies of the C-terminal domain of Rv3262 (FbiB) from Mycobacterium tuberculosis.

Authors:  Aisyah M Rehan; Ghader Bashiri; Neil G Paterson; Edward N Baker; Christopher J Squire
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-09-30

2.  Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst.

Authors:  D L Piddington; F C Fang; T Laessig; A M Cooper; I M Orme; N A Buchmeier
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 3.  Nitric oxide and redox mechanisms in the immune response.

Authors:  David A Wink; Harry B Hines; Robert Y S Cheng; Christopher H Switzer; Wilmarie Flores-Santana; Michael P Vitek; Lisa A Ridnour; Carol A Colton
Journal:  J Leukoc Biol       Date:  2011-01-13       Impact factor: 4.962

4.  The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A.

Authors:  Philip O'Reilly; Judy M Hickman-Davis; Philip McArdle; K Randall Young; Sadis Matalon
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 5.  Disruption of immune regulation by microbial pathogens and resulting chronic inflammation.

Authors:  Kenneth Barth; Daniel G Remick; Caroline A Genco
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

6.  Reactive nitrogen intermediates have a bacteriostatic effect on Mycobacterium tuberculosis in vitro.

Authors:  Marcia A Firmani; Lee W Riley
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

7.  Requirements for nitric oxide generation from isoniazid activation in vitro and inhibition of mycobacterial respiration in vivo.

Authors:  Graham S Timmins; Sharon Master; Frank Rusnak; Vojo Deretic
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

8.  Nitric Oxide Synthesis is Modulated by 1,25-Dihydroxyvitamin D3 and Interferon-gamma in Human Macrophages after Mycobacterial Infection.

Authors:  Ji-Sook Lee; Chul-Su Yang; Dong-Min Shin; Jae-Min Yuk; Ji-Woong Son; Eun-Kyeong Jo
Journal:  Immune Netw       Date:  2009-10-30       Impact factor: 6.303

9.  Mycobacteria inhibit nitric oxide synthase recruitment to phagosomes during macrophage infection.

Authors:  Barbara H Miller; Rutilio A Fratti; Jens F Poschet; Graham S Timmins; Sharon S Master; Marcos Burgos; Michael A Marletta; Vojo Deretic
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  Nitric oxide generated from isoniazid activation by KatG: source of nitric oxide and activity against Mycobacterium tuberculosis.

Authors:  Graham S Timmins; Sharon Master; Frank Rusnak; Vojo Deretic
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.